| All n= 479 (100%) | 2005 n= 176 (36.7%) | 2023 N = 303 (63.3) | p |
Male sex, n (%) | 201 (42.0) | 65 (36.9) | 136 (44.9) | 0.08 |
Median (interquartile range) | ||||
T2DM duration (years) | 5.0 (1.0 - 11.0) | 4.0 (2.0 - 9.0) | 5.0 (0.0 - 12.0) | 0.54 |
Age (years) | 59.0 (53.0 - 68.0) | 58.0 (52.0 - 66.0) | 60.0 (53.0 - 68.0) | 0.27 |
SBP (mmHg) | 139.0 (125.0 - 157.0) | 140.0 (124.0 - 159.5) | 138.0 (125.0 - 156.0) | 0.60 |
DBP (mmHg) | 86.0 (78.0 - 96.0) | 88.0 (79.0 - 97.0) | 84.0 (77.0 - 94.0) | 0.006 |
BMI (Kg/m2) | 25.5 (22.2 - 30.2) | 24.5 (21.3 - 28.3) | 26.4 (22.7 - 31.1) | 0.0003 |
WC (cm) | 92.0 (82.0 - 101.0) | 89.5 (79.0 - 96.0) | 94.3 (83.0 - 103.0) | <0.0001 |
W/H | 0.57 (0.51 - 0.63) | 0.56 (0.50 - 0.61) | 0.58 (0.52 - 0.64) | 0.002 |
TC (mg/dl) | 185.0 (151.4 - 211.7) | 170.5 (142.0 - 201.5) | 208.0 (162.1 - 224.0) | <0.0001 |
HDL-C (mg/dl) | 52.0 (41.0 - 73.3) | 41.0 (35.0 - 49.0) | 61.7 (46.3 - 81.0) | <0.0001 |
LDL-C (mg/dl) | 110.4 (90.0 - 146.7) | 104.1 (81.9 - 128.5) | 115.0 (96.3 - 152.0) | <0.0001 |
Non-HDL-C (mg/dl) | 127.4 (100.3 - 158.2) | 125.5 (103.0 - 154.5) | 127.4 (100.3 - 162.1) | 0.84 |
TG (mg/dl) | 126.0 (88.4 - 163.5) | 103.5 (73.5 - 140.5) | 160.0 (154.0 - 166.0) | 0.001 |
TG/HDL-C | 2.3 (1.5 - 3.4) | 2.6 (1.7 - 3.8) | 2.1 (1.52 - 3.16) | 0.01 |
Albumin (g/L) | - | - | 3.53 (32.7 - 38.0) | - |
Homa S (%) | 75.9 (32.2 - 128.1) | 113.0 (71.5 - 159.0) | 45.3 (23.8 - 102.7) | <0.0001 |
Homa B (%) | 38.1 (18.5 - 68.6) | 28.0 (12.6 - 53.2) | 46.6 (24.6 - 83.8) | <0.0001 |
Frequency, n (%) | ||||
T2DM without IR | 204 (42.6) | 100 (56.8) | 104 (34.3) | <0.0001 |
T2DM with IR | 177 (37.0) | 23 (13.1) | 154 (50.8) | <0.0001 |
MetS score ≥ 3/5 | 350 (73.1) | 125 (71.0) | 225 (74.3) | 0.44 |
Overall obesity | 126 (26.3) | 30 (17.0) | 96 (31.7) | 0.0005 |
Abdominal obesity | 208 (43.4) | 57 (32.4) | 151 (49.8) | 0.0002 |
W/H > 0.5 | 196 (55.4) | 57 (32.4) | 139 (78.1) | <0.0001 |
TG/HDL-C ratio > 5.0 | 55 (11.6) | 21 (11.9) | 34 (11.4) | 0.85 |